PortfoliosLab logoPortfoliosLab logo
GSKH vs. ARKG
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GSKH vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GSK plc ADRhedged ETF (GSKH) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GSKH achieves a 9.31% return, which is significantly lower than ARKG's 38.45% return.


GSKH

1D
0.80%
1M
2.24%
YTD
9.31%
6M
9.50%
1Y
43.24%
3Y*
5Y*
10Y*

ARKG

1D
3.97%
1M
28.15%
YTD
38.45%
6M
32.90%
1Y
65.40%
3Y*
7.15%
5Y*
-14.83%
10Y*
10.24%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GSKH vs. ARKG - Yearly Performance Comparison


2026 (YTD)2025
GSKH
GSK plc ADRhedged ETF
9.31%36.51%
ARKG
ARK Genomic Revolution Multi-Sector ETF
38.45%10.74%

Correlation

The correlation between GSKH and ARKG is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Jan 7, 2025

0.16

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GSKH vs. ARKG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GSKH
GSKH Risk / Return Rank: 5252
Overall Rank
GSKH Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
GSKH Sortino Ratio Rank: 5757
Sortino Ratio Rank
GSKH Omega Ratio Rank: 5555
Omega Ratio Rank
GSKH Calmar Ratio Rank: 5353
Calmar Ratio Rank
GSKH Martin Ratio Rank: 4141
Martin Ratio Rank

ARKG
ARKG Risk / Return Rank: 4949
Overall Rank
ARKG Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 5252
Sortino Ratio Rank
ARKG Omega Ratio Rank: 4444
Omega Ratio Rank
ARKG Calmar Ratio Rank: 5656
Calmar Ratio Rank
ARKG Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GSKH vs. ARKG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GSK plc ADRhedged ETF (GSKH) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GSKHARKGDifference
Sharpe ratioReturn per unit of total volatility

+0.14

Sortino ratioReturn per unit of downside risk

+0.23

Omega ratioGain probability vs. loss probability

1.31

1.25

+0.05

Calmar ratioReturn relative to maximum drawdown

2.34

2.39

-0.05

Martin ratioReturn relative to average drawdown

6.07

5.69

+0.38

GSKH vs. ARKG - Sharpe Ratio Comparison

The current GSKH Sharpe Ratio is 1.66, which is comparable to the ARKG Sharpe Ratio of 1.52. The chart below compares the historical Sharpe Ratios of GSKH and ARKG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GSKH vs. ARKG - Drawdown Comparison

The maximum GSKH drawdown since its inception was -18.54%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for GSKH and ARKG.


Loading charts...

Drawdown Indicators


GSKHARKGDifference

Max Drawdown

Largest peak-to-trough decline

-18.54%

-83.59%

+65.05%

Max Drawdown (1Y)

Largest decline over 1 year

-18.54%

-27.51%

+8.97%

Max Drawdown (3Y)

Largest decline over 3 years

-51.96%

Max Drawdown (5Y)

Largest decline over 5 years

-80.18%

Max Drawdown (10Y)

Largest decline over 10 years

-83.59%

Current Drawdown

Current decline from peak

-12.10%

-64.11%

+52.01%

Average Drawdown

Average peak-to-trough decline

-5.90%

-36.04%

+30.14%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.15%

11.53%

-4.38%

Volatility

GSKH vs. ARKG - Volatility Comparison

The current volatility for GSK plc ADRhedged ETF (GSKH) is 7.07%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 16.58%. This indicates that GSKH experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GSKHARKGDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.07%

16.58%

-9.51%

Volatility (6M)

Calculated over the trailing 6-month period

18.72%

31.63%

-12.91%

Volatility (1Y)

Calculated over the trailing 1-year period

26.18%

43.20%

-17.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.91%

46.07%

-19.16%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.91%

41.35%

-14.44%

GSKH vs. ARKG - Expense Ratio Comparison

GSKH has a 0.19% expense ratio, which is lower than ARKG's 0.75% expense ratio.


Dividends

GSKH vs. ARKG - Dividend Comparison

GSKH's dividend yield for the trailing twelve months is around 2.84%, while ARKG has not paid dividends to shareholders.


PositionTTM202520242023202220212020201920182017
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%
GSKH
GSK plc ADRhedged ETF
2.84%1.15%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


GSKH and ARKG have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ARKG has higher volatility (16.58%) compared to GSKH (7.07%). In terms of maximum drawdown, GSKH dropped -18.54% vs ARKG's -83.59%.

On 1-year performance, ARKG leads with 65.40% vs 43.24% for GSKH. On fees, GSKH is cheaper at 0.19% per year. On volatility, GSKH has been the lower-risk option at 7.07%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, ARKG has performed better with a 65.40% return vs 43.24%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

GSKH is cheaper with a 0.19% expense ratio, compared with 0.75% for ARKG.

GSKH has the higher dividend yield at 2.84%, compared with 0.00% for ARKG.

They also come from different issuers: ADRhedged and ARK. Their fees differ too: 0.19% for GSKH and 0.75% for ARKG.

GSKH currently has the higher Sharpe Ratio (1.66 vs 1.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GSKH and ARKG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer